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Report
 
RAF1-activated MEK1 is found on the Golgi apparatus 
in late prophase and is required for Golgi complex 
fragmentation in mitosis
 
Antonino Colanzi, Christine Sutterlin, and Vivek Malhotra
 
Cell and Developmental Biology, University of California, San Diego, La Jolla, CA 92093
 
mitotically activated mitogen-activated protein ki-
nase 1 (MEK1) fragments the pericentriolar Golgi
stacks in mammalian cells. We show that activated
MEK1 is found on the Golgi apparatus in late prophase.
The fragmented and dispersed Golgi membranes in pro-
metaphase and later stages of mitosis do not contain activated
A
 
MEK1. MEK1-dependent Golgi complex fragmentation is
through activation by RAF1 and not MEK1 kinase 1. We
propose that a RAF1-dependent activation of MEK1 and its
presence on the Golgi apparatus in late prophase is required
for Golgi complex fragmentation.
 
Introduction
 
Mammalian cells contain 
 
 
 
100 stacks of Golgi cisternae
 
organized in a contiguous ribbonlike structure concentrated
in the pericentriolar region. In mitosis, the Golgi membranes
are highly fragmented and dispersed throughout the cell. This
fragmentation is thought to be necessary for partitioning
Golgi membranes between daughter cells during cell division
(Warren, 1993). Evidence in support of this proposal comes
from the recent findings that preventing fragmentation and
dispersal of the pericentriolar Golgi apparatus prevents mam-
malian cells from entering mitosis (Sutterlin et al., 2002).
We have taken the following approach to identify compo-
nents involved in the fragmentation of pericentriolar Golgi
apparatus. Normal rat kidney (NRK)* cells grown on cover-
slips are permeabilized with ice-cold digitonin and washed
with a buffer containing 1 M KCl to remove cytosolic and
loosely attached peripheral membrane proteins. The perme-
abilized and salt-washed cells are incubated at 32
 
 
 
C for 60
 
min with cytosol prepared from mitotic NRK cells. The
organization of Golgi membranes is monitored by fluorescence
microscopy using antibodies to Golgi complex–specific proteins
such as mannosidase II (ManII). As a result of this procedure,
the Golgi apparatus is fragmented and dispersed in tubulo-
reticular membranes throughout the cytoplasm (Acharya et
al., 1998; Colanzi et al., 2000). We have previously shown
that mitotically activated mitogen-activated protein kinase 1
(MEK1) and Polo-like kinase 1 are required for Golgi complex
fragmentation (Acharya et al., 1998; Colanzi et al., 2000;
Sutterlin et al., 2001). We now report that RAF1 is required
to activate MEK1 for Golgi complex fragmentation during
mitosis and that mitotically activated MEK1 is found on the
Golgi membranes in late prophase.
 
Results and discussion
 
RAF1-dependent activation of MEK1 is necessary for 
Golgi complex fragmentation
 
There are at least two different kinases known to activate
MEK1: RAF1 and MEK kinase 1 (MEKK1; Garrington and
Johnson, 1999). RAF1 regulates cell proliferation in response
to growth factors, cytokines, and hormones (Morrison and
Cutler, 1997). It is not clear how RAF1 activity is regulated,
but a Ras-dependent membrane recruitment, phosphorylation
on multiple sites, and binding to several proteins (such as
14–3-3 and heat shock proteins 90/50) are some of the key
factors (Kolch, 2000). The activation of RAF1 during mitosis
follows a different and specific mechanism that does not require
Ras or binding to membranes, but involves the protein kinase
Pak1 (Ziogas et al., 1998; Laird et al., 1999; Zang et al.,
2001, 2002).
We tested whether RAF1 is required for MEK1-dependent
mitosis-specific Golgi complex fragmentation. There are no
known RAF1-specific inhibitors and it is also difficult to
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deplete RAF1 from mitotic cytosol without using deter-
gents. Therefore, we used the following strategy to specifi-
cally block RAF1 activation. We expressed a GST-tagged
deletion mutant of RAF1 (corresponding to amino acids
1–239) in 
 
Escherichia coli
 
 (Fig. 1 A). This peptide corre-
sponds to the autoinhibitory domain of RAF1 and acts as
dominant negative inhibitor of RAF1 when expressed in
mammalian cells (Flory et al., 1998). Purified recombinant
GST-RAF1/1-239 (Raf-239) was added to mitotic cytosol
for 10 min at 32
 
 
 
C with ATP. The endogenous RAF1 was
immunoprecipitated from this incubation mixture using an
 
antibody against the COOH terminus of RAF1. The im-
munoprecipitated RAF1 (on beads) was incubated with
recombinant MEK1 and ATP at 32
 
 
 
C. The sample was
centrifuged to separate MEK1 (supernatant) from RAF1
(beads). RAF1 is known to phosphorylate MEK1 at serines
218 and 222 and the extent of this double phosphorylation
is a reliable indicator of RAF1 activity (Bondzi et al., 2000).
The supernatant containing MEK1 was analyzed by SDS-
PAGE followed by Western blotting with an antibody that
recognizes MEK1 phosphorylated at serines 218 and 222
(anti–phospho-MEK [ppMEK] antibody). Incubation of
mitotic cytosol with recombinant Raf-239 inhibited RAF1
activation (Fig. 1 B). Quantitation of the Western blot re-
vealed that Raf-239 causes a 75% inhibition of RAF1 activ-
ity toward MEK1 (Fig. 1 B, bottom). Similar results were
obtained with GST-RAF1/1-330 (Raf-330), which corre-
sponds to the entire regulatory domain of RAF1 (Fig. 1 A).
For the experiments described below, we used Raf-239 be-
cause it was easier to express and purify. Raf-239 most
likely interferes with the complex network of proteins that
regulates RAF1 function titrating out activating compo-
nents (Bruder et al., 1992; Flory et al., 1998). Raf-239 does
not titrate out MEK1 because the MEK1 binding sites are
located in the COOH-terminal catalytic domain of RAF1
(Yeung et al., 2000).
We then tested the effect of Raf-239 on the Golgi com-
plex fragmentation induced by mitotic cytosol in perme-
abilized cells. Mitotic cytosol was preincubated for 10 min
at 32
 
 
 
C in the presence of ATP and Raf-239 and added to
permeabilized NRK cells for 60 min. Cells were then fixed
and analyzed by immunofluorescence microscopy. Addi-
tion of 15 
 
 
 
g of Raf-239 to the assay inhibited Golgi com-
plex fragmentation in 
 
 
 
70% of the cells (Fig. 1, C and D).
Importantly, addition of recombinant constitutively acti-
vated MEK1 (G1C) alleviated the inhibition of Golgi com-
plex fragmentation induced by Raf-239. Thus, inhibition
of Golgi complex fragmentation by Raf-239 is a conse-
quence of specific inhibition of RAF1-dependent MEK1
activation.
An additional strategy was used to interfere with the
RAF1–MEK1 pathway by using RAF1 kinase inhibitory
protein (RKIP). In the presence of RKIP, RAF1 can-
not bind MEK1 (Yeung et al., 2000). RKIP does not in-
hibit MEKK1-mediated phosphorylation and activation of
MEK1 (Yeung et al., 1999). RAF1 and MEKK1 were im-
munoisolated from mitotic cytosol using anti-RAF1 and
anti-MEKK1 antibodies conjugated to Sepharose beads, re-
spectively. The beads containing immunoisolated RAF1
and MEKK1 were incubated with MEK1, RKIP, and ATP
at 32
 
 
 
C for 10 min. The reaction mixture was centrifuged
to separate beads from soluble MEK1. The supernatant
containing MEK1 was analyzed by SDS-PAGE and West-
ern blotted with anti-ppMEK antibody. Our results show
that RKIP inhibited RAF1-mediated phosphorylation of
MEK1, but did not affect MEKK1-mediated phosphoryla-
tion of MEK1 (Fig. 2 A). This is in agreement with the
work of Yeung and colleagues (Yeung et al., 1999). Recom-
binant purified RKIP was incubated with mitotic cytosol
and this sample added to the assay reconstituting Golgi
complex fragmentation process. RKIP strongly inhibited
Figure 1. Raf-239 inhibits endogenous RAF1 activation and Golgi 
complex fragmentation. (A) A schematic diagram of RAF1 domains. 
Full-length (FL) RAF1 is composed of a COOH-terminal catalytic 
domain (CD) and NH2-terminal regulatory domain containing a 
cysteine-rich domain (C1) and a serine/threonine rich-domain (ST). 
(B) Mitotic cytosol (350  g) was incubated with buffer alone, 50  g 
GST, or 15  g Raf-239 for 10 min at 32 C. Endogenous RAF1 was 
immunoprecipitated with 2  g anti-RAF1 (C-12) antibody complexed 
to beads. The samples containing immunoprecipitated RAF1 were 
incubated with 3  g recombinant MEK1 for 10 min at 32 C in the 
presence of ATP. At the end of the incubation, MEK1 was recovered 
and immunoblotted with anti-ppMEK antibody. The quantitation 
of the results is shown in the lower panel. The extent of MEK1 
phosphorylation is used as an indication of RAF1 activity. Raf-239 
inhibits activation of the endogenous RAF1 by 75%. The quantification 
of the experiment shown in the figure is presented; similar results 
have been obtained in four different experiments. (C) Mitotic extract 
treated with Raf-239 as described above was applied to permeabilized 
cells. The organization of the Golgi membranes was analyzed 
by fluorescence microscopy using the anti-ManII antibody. 
(D) Quantitation of the effects of Raf-239 on Golgi complex 
fragmentation by mitotic cytosol. Raf-239 inhibited the mitotic-
specific Golgi complex fragmentation. The addition of 3  g of 
bacterially expressed constitutive active MEK1 (G1C) restored Golgi 
complex fragmentation. The data represent the average of seven 
different experiments.T
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mitotic cytosol–dependent Golgi complex fragmentation
(Fig. 2, B and C). Addition of recombinant constitutively
activated MEK1 (G1C) significantly restored Golgi com-
plex fragmentation activity of mitotic cytosol containing
RKIP. The restoration of Golgi complex fragmentation
activity was partial because RKIP is required in molar ex-
cess concentration to efficiently inhibit RAF1-dependent
MEK1 activation (Yeung et al., 1999). The addition of
higher concentration of G1C, sufficient to fully revert the
inhibition, is not feasible in our assay because it dilutes the
concentration of mitotic cytosol necessary for Golgi com-
plex fragmentation. These results provide strong evidence
that RAF1-mediated activation of MEK1 is required for
Golgi complex fragmentation by mitotic cytosol. We have
previously shown that mitotically activated MEK1 is con-
formationally different from its functional counterpart in
interphase cells (Colanzi et al., 2000). Partial proteolysis of
His-MEK1 incubated with mitotic cytosol reveals a 20-kD
phosphopeptide, which is not observed upon proteolysis of
His-MEK1 incubated with interphase cytosol. RAF1 was
isolated from mitotic cytosol and incubated with His-
MEK1. This preparation of His-MEK1 was subjected to
partial proteolysis. The resulting proteolytic fragments did
not contain the 20-kD phosphopeptide described above
(unpublished data). Together, these results suggest that
RAF1 is required, but is not sufficient for complete mitosis-
specific activation of MEK1. The identity of additional
components required for MEK1 activation in Golgi com-
plex fragmentation is not known.
 
Inhibiting RAF1 activation prevents entry into mitosis
 
It has recently been suggested that RAF1 is specifically ac-
tivated during mitosis (Laird et al., 1999; Zang et al.,
2001, 2002). However, formal proof that RAF1 is required
to enter mitosis is lacking. NRK cells were arrested in
S-phase with aphidicolin. The cells were subsequently
washed to remove aphidicolin, 5 h after aphidicolin re-
moval, 400 cells were injected either with Raf-239 or GST.
2 h after injection, the cells were fixed and visualized by
fluorescence microscopy to monitor the organization of
DNA and Golgi apparatus. The mitotic index of the in-
jected cells was determined relative to that of the nonin-
jected cells in the same coverslip. The mitotic index of cells
injected with GST was 91 
 
 
 
 11. The mitotic index of cells
injected with Raf-239 was 41 
 
 
 
 8 (Fig. 3). Thus, injection
of Raf-239 inhibited entry into mitosis in 
 
 
 
50% of cells.
These results strengthen the proposal that a RAF1–MEK1-
mediated process is necessary for entry into mitosis in
mammalian cells.
 
Activated MEK1 is found on the Golgi membranes 
during late prophase
 
Our previous findings revealed that MEK1-mediated Golgi
complex fragmentation was independent of its well-known
cytosolic substrates called extracellular signal-regulated ki-
nases (ERKs; Acharya et al., 1998; Colanzi et al., 2000).
This suggested that MEK1 could directly bind to Golgi
Figure 2. RKIP does not block MEKK1-dependent MEK1 activation, 
but inhibits RAF1-dependent MEK1 activation and Golgi complex 
fragmentation. (A) RAF1 and MEKK1 were immunoprecipitated 
from 250  g mitotic cytosol using 2  g of C-12 and 43-Y antibodies, 
respectively. The beads were subsequently incubated with 3  g 
recombinant MEK1 for 10 min at 32 C in the presence of buffer alone, 
50  g BSA, or 15  g RKIP. MEK1 was recovered by centrifugation 
and immunoblotted with anti-ppMEK antibody. Quantitation of the 
results is shown in the lower panel. RKIP inhibits RAF1-dependent 
MEK1 activation. The quantification of the experiment shown in 
the figure is presented; similar results have been obtained in three 
different experiments. (B) Mitotic extract treated with RKIP as 
described above was added to permeabilized cells. The organization 
of the Golgi membranes was analyzed by fluorescence microscopy 
using the anti-ManII antibody. (C) Quantification of the effects of 
RKIP on Golgi complex fragmentation by mitotic cytosol. Inhibition 
of the RAF1-dependent MEK1 activation inhibited the mitotic-
specific Golgi complex fragmentation. The addition of 3  g of 
bacterially expressed constitutive active MEK1 (G1C) restored the 
Golgi complex fragmentation. The data represent the average of six 
different experiments.
Figure 3. RAF1 is required for entry 
into mitosis. NRK cells were arrested in 
S-phase with aphidicolin. The cells were 
washed to remove aphidicolin and 
injected 5 h later with Raf-239 or GST. 
After an additional incubation for 2 h, 
the cells were stained with Golgi complex 
and DNA-specific markers. 400 cells 
were counted for each experimental 
condition to calculate the mitotic index. 
The mitotic index is the ratio of the 
percentage of mitotic cells in the pool 
of injected of cells compared with 
noninjected cells on the same coverslip. The mitotic index of cells 
injected with GST was found to be 91   11 as compared with 41   8 
for the Raf-239–injected cells. The data are calculated from 16 
independent experiments.T
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membranes and initiate fragmentation via a Golgi complex–
specific substrate. If this is correct, MEK1 should bind to
Golgi membranes during the fragmentation process. The
cellular localization of activated MEK1 during mitosis was
examined by staining NRK cells with anti-ppMEK antibody
(Willard and Crouch, 2001). The cells were also stained
with Hoechst, and antibodies to the Golgi protein 
 
 
 
-COP
or Giantin to identify the mitotic stage and reveal the orga-
nization of Golgi membranes, respectively.
Activated MEK1 showed nuclear localization during
prophase (Fig. 4 A). This is in agreement with the fact that
MEK1 translocates to the nucleus during this mitotic stage
(Tolwinski et al., 1999). Interestingly, activated MEK1 was
localized to the Golgi apparatus in late prophase (Fig. 4 A).
To ensure that the Golgi complex–specific staining of
ppMEK antibody was due to interaction with activated
MEK1, cells were stained with ppMEK antibody that had
been preincubated with either mitotically activated recom-
binant MEK1 (phosphorylated MEK1) or unphosphory-
lated recombinant MEK1. Preincubation of ppMEK anti-
body with mitotically phosphorylated MEK1 abolished the
Golgi complex and nuclear staining. ppMEK antibody
staining on the Golgi apparatus in late prophase, therefore,
is due to its binding to the mitotically activated MEK1
(Fig. 4 B). The percentage of the 
 
 
 
-COP positive structures
that contained mitotically activated MEK1 was 47 
 
  
 
6%.
Figure 4. Activated MEK1 is found on the Golgi 
apparatus in late prophase. NRK cells were blocked 
in S-phase with aphidicolin. The cells were washed 
to remove aphidicolin. 7 h after aphidicolin removal, 
cells were processed for fluorescence microscopy 
to visualize the Golgi apparatus, activated MEK1, 
and DNA with antibodies against  -COP, ppMEK, 
and the DNA-specific dye Hoechst, respectively. 
(A) Confocal microscopy image showing that 
activated-MEK1 is localized to the Golgi apparatus 
in late prophase (condensed DNA*) and not in 
interphase (uncondensed DNA). (B) Epifluorescence 
microscopy image showing cells stained with 
ppMEK antibody that had been preincubated with 
either mitotically activated MEK (phosphorylated 
MEK1) or unphosphorylated MEK1. Preincubation 
of ppMEK antibody with mitotically phosphorylated 
MEK1 abolished the Golgi complex–specific staining 
of cells in late prophase (condensed DNA*). 
Therefore, ppMEK antibody staining is due to the 
presence of activated MEK1 on the Golgi apparatus.
 
Table I. 
 
Quantitation of cells containing activated MEK1 on Golgi membranes during mitosis
Stage
Fraction of cells containing 
phospho-MEK on Golgi membranes
Cells containing 
phospho-MEK on Golgi membranes
 
%
 
Interphase  0/50   0
Early prophase  0/35  0
Middle prophase  2/46  4
Late prophase 24/29 83
Prometaphase  4/50  7
Metaphase to cytokinesis 0/50 0
NRK cells treated as described in Fig. 4 were labeled for activated MEK1 and DNA and imaged by fluorescence microscopy. The mitotic stages were defined
based on the level of chromosome condensation. The number of cells with activated MEK1 on the Golgi complex (numerator) and the number of cells
counted (denominator) are shown. 83% of cells in late prophase contain activated MEK1 on Golgi membranes.T
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Similar results were obtained in HeLa, NIH, and COS-7
cells (not depicted).
The number of cells with Golgi complex localized acti-
vated MEK1 was quantified and the results are shown in
Table I. About 83% of cells in late prophase exhibited
Golgi complex–specific localization of mitotically activated
MEK1. Cells at mitotic stages before or after late prophase
did not contain mitotically activated MEK1 on Golgi mem-
branes (Fig. 4 A and Fig. 5). Together, these finding provide
strong evidence that mitotically activated MEK1 is present
on the Golgi membranes in late prophase.
Activated MEK1 is found attached to astral microtubules
in metaphase, polar microtubules in anaphase, and finally in
the central spindle microtubules in cells in cytokinesis (Fig.
5). Therefore, activated MEK1 interacts with different cellu-
lar components to (most likely) catalyze different reactions
depending on its location.
 
Conclusions
 
The timing of the appearance of activated MEK1 on the
Golgi apparatus coincides with the initiation of Golgi com-
plex fragmentation during mitosis. One of the components
necessary for the activation of MEK1 in the Golgi complex
fragmentation process is RAF1. Circumstantial evidence in-
dicates that an ERK-like protein may be the downstream
target of MEK1. An ERK-like protein or a mitotically acti-
vated ERK with novel modification has been found on the
Golgi membranes (Acharya et al., 1998; Cha and Shapiro,
2001). It is also reported that ERK2 phosphorylates the
Golgi complex–associated complex protein GRASP55
(Jesch et al., 2001). It is conceivable that a RAF1–MEK1–
ERK/ERK-like pathway induces the phosphorylation of
GRASP55 during mitosis and consequently destabilizes the
Golgi stacks. This reaction, along with reactions catalyzed
by Polo-like kinase 1 and the cdc2 kinase, may well explain
the mechanism of Golgi complex fragmentation during mi-
tosis (Lowe et al., 1998; Sutterlin et al., 2001).
 
Materials and methods
 
Reagents, antibodies, and cells
 
All biochemical reagents were obtained from the sources described before
unless otherwise mentioned (Acharya et al., 1998; Colanzi et al., 2000).
The anti–COOH-terminal MEK1 (C-18), RAF1 (C-12), and MEKK-1 (43-Y)
were purchased from Santa Cruz Biotechnology. The ppMEK antibody was
purchased from Cell Signaling Technology. Constructs for the expression
of recombinant His-MEK1 and His-G1C (constitutively active MEK1) were
a gift from N. Ahn (University of Colorado at Boulder, Boulder, CO). Bac-
terial expression vectors for Raf-239 and Raf-330 were a gift from S.J.
Decker (University of Michigan, Ann Arbor, MI). Bacterial expression plas-
mid for RKIP was a gift from K. Yeung and W. Kolch (Brown University,
Providence, RI).
 
Preparation of mitotic extract, Raf-239, and RKIP
 
Preparation of cytosol from NRK cells arrested in mitosis and the assay for
Golgi complex fragmentation have been described before (Acharya et al.,
1998). Raf-239 and RKIP were expressed and purified by the published
procedure (Pumiglia et al., 1995; Yeung et al., 1999). The recombinant
proteins were dialyzed against KHM buffer containing 5% glycerol and
stored at –80
 
 
 
C.
Figure 5. Intracellular distribution of 
activated MEK1 during mitosis. Cells 
were treated as described in Fig. 4 A and 
processed for confocal fluorescence 
microscopy by staining the Golgi 
apparatus, activated MEK1, and DNA 
with antibodies against  -COP, ppMEK, 
and the DNA-specific dye Hoechst, 
respectively.T
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Assay of endogenous RAF activity
 
The assay was performed as described previously (Bondzi et al., 2000)
with the following modifications. 15 
 
 
 
g of Raf-239 RAF1 was added to
350 
 
 
 
g of mitotic cytosol. After a 10-min incubation at 32
 
 
 
C in the pres-
ence of ATP, the endogenous RAF1 was immunoprecipitated from the in-
cubation mixture using 2 
 
 
 
g of anti-RAF1 antibody raised against the
COOH terminus of the protein. The immunoprecipitated RAF1 (still on
beads) was then incubated with 3 
 
 
 
g of recombinant MEK1 and ATP at
32
 
 
 
C. The sample was centrifuged to separate MEK1 (in the supernatant)
from RAF1 (on the beads). The supernatant was analyzed by SDS-PAGE
followed by Western blotting with anti-ppMEK antibody. The film was
scanned and the bands quantitated using the Kodak 1D 3.0 software.
 
Assay for MEK1 activation
 
RAF1 and MEKK1 were immunoisolated from 250 
 
 
 
g of mitotic cytosol us-
ing 2 
 
 
 
g of anti-RAF1 and anti-MEKK1 antibodies conjugated to Sepharose
beads. The beads containing immunoisolated RAF1 and MEKK1 were in-
cubated as described (Bondzi et al., 2000) with MEK1, RKIP, and ATP at
32
 
 
 
C for 10 min. The reaction was then centrifuged to separate beads from
the soluble MEK1. The supernatant containing MEK1 was analyzed by
SDS-PAGE and Western blotted with anti-ppMEK antibody and analyzed
as reported above.
 
Microinjections
 
Purified GST and Raf-239 were injected into NRK cells by the same proce-
dures as described previously for GRAPS65-related reagents (Sutterlin et
al., 2002).
 
Effect of Raf-239 and RKIP on Golgi complex fragmentation
 
350 
 
 
 
g of mitotic extract was pretreated with Raf-239 or RKIP (15 
 
 
 
g/sam-
ple) and an ATP regeneration system for 10 min at 32
 
 
 
C. This mixture was
added to semi-intact cells and the incubation was performed for 1 h at
32
 
 
 
C. G1C was used at a final concentration of 3 
 
 
 
g/sample. The mixture
was incubated for 10 min at 32
 
 
 
C in the presence of an ATP regeneration
system and then added to semi-intact cells for 60 min at 32
 
 
 
C.
 
Localization of activated MEK1
 
NRK cells were plated and treated as described before (Sutterlin et al.,
2002). Cells were fixed with 4% formaldehyde at 37
 
 
 
C and blocked with
PBS containing 0.1% TX-100 and 5% BSA. To reveal the localization of
activated MEK1, cells were incubated for 2 h at room temperature in
blocking buffer containing 2 
 
 
 
g/ml of ppMEK1 antibody followed by a
1-h incubation with goat anti–rabbit Alexa-546 (1:3,000 dilution). All
the other staining procedures were as described (Sutterlin et al., 2002).
Epifluorescence microscopy images were acquired with a Nikon micro-
phot-FXA connected to an Olympus CCD camera. Confocal microscope
images were captured on a Leika microscope using 488-nm laser excita-
tion for secondary Alexa486, 568 nm for Alexa546, and 351 nm for
Hoechst dye. Images for illustrations were captured with a 60 NA objec-
tive. Microsoft PowerPoint and Adobe Photoshop 7.0 were used to
assemble the figures. To calculate the extent of active MEK1 colocaliza-
tion with 
 
 
 
-COP, five images showing double labeling for active MEK1
and 
 
 
 
-COP were selected, the respective Golgi complex areas were se-
lected and cut using Adobe Photoshop. Finally, the NIH Image software
(version 1.62) was used to measure the percentage of the 
 
 
 
-COP con-
taining pixels and active MEK1. To evaluate the specificity of ppMEK an-
tibody, immunofluorescence blocking buffer containing 0.2 
 
 
 
g/ml of
ppMEK antibody were incubated with a 50-M excess of recombinant
MEK1 that had been previously phosphorylated as described above.
Control sample consisted of ppMEK antibody incubated with nonphos-
phorylated recombinant MEK1.
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